Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Lysis Syndrome”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03605212
What this trial is testing

Febuxostat for Tumor Lysis Syndrome Prevention in Hematological Malignancies of Paediatric Patients and Adults

Who this might be right for
Tumor Lysis Syndrome
Menarini Group 30
Post-approval studies (Phase 4)Study completedNCT00230217
What this trial is testing

Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy

Who this might be right for
TumorsHyperuricemiaTumor Lysis Syndrome
Sanofi 94
Large-scale testing (Phase 3)Study completedNCT00230178
What this trial is testing

Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome

Who this might be right for
Tumor Lysis SyndromeCancerHyperuricemia
Sanofi 280
Testing effectiveness (Phase 2)Study completedNCT01200485
What this trial is testing

Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 55
Testing effectiveness (Phase 2)Study completedNCT00628628
What this trial is testing

Rasburicase in Patients at Risk for Tumor Lysis Syndrome

Who this might be right for
Tumor Lysis Syndrome
M.D. Anderson Cancer Center 82
Post-approval studies (Phase 4)Study completedNCT00651911
What this trial is testing

Fasturtec TLS Treatment / Prophylysis

Who this might be right for
Tumor Lysis Syndrome
Sanofi 45
Post-approval studies (Phase 4)Study completedNCT04745910
What this trial is testing

Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmTumor Lysis Syndrome
M.D. Anderson Cancer Center 10